CN1171617C - Chinese medicine for treating cervical spondylosis - Google Patents
Chinese medicine for treating cervical spondylosis Download PDFInfo
- Publication number
- CN1171617C CN1171617C CNB021256470A CN02125647A CN1171617C CN 1171617 C CN1171617 C CN 1171617C CN B021256470 A CNB021256470 A CN B021256470A CN 02125647 A CN02125647 A CN 02125647A CN 1171617 C CN1171617 C CN 1171617C
- Authority
- CN
- China
- Prior art keywords
- portions
- processed
- cervical spondylosis
- chinese medicine
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to Chinese medicine for treating cervical spondylosis, which is characterized in that the present invention is prepared from 50 to 160 portions of processed myrrh, 25 to 80 portions of forged pyrite, 30 to 95 portions of processed medicated leaven, 15 to 50 portions of ground beeltle, 10 to 40 portions of notoginseng, 75 to 240 portions of earthworm, 50 to 160 portions of stiff silkorm, 2 to 15 portions of dragon's blood, 1 to 5 portions of pearl powder, 180 to 600 portions of processed nuxvomica and 50 to 150 portions of processed frankincense. The present invention is processed into capsules according to the conventional method, and has the efficiency of promoting blood circulation, removing blood stasis, dredging the meridian passage, regulating the liver, invigorating the kidney and removing cold, dampness and exogenous evil qi. For treating cervical spondylosis, the present invention has the advantages and effects of short course of treatment, obvious effect, low cost, no side effect, no risk, no pain and no recrudescence.
Description
(1) technical field
The present invention relates to a kind of Chinese medicine for the treatment of cervical spondylosis, specifically it is to be the capsule that raw material is made according to a conventional method with Chinese medicine, belongs to the field of Chinese medicines.
(2) background technology
Cervical spondylosis is a kind of sickness rate height, and be difficult to one of persistent ailment of curing again, its cause of disease is mostly because damaged by external force the day after tomorrow in the developmental process, strain, the local QI and blood stasis of blood is long-pending, nutrient delivery is not smooth, Liver and kidney gradually loses, asthenia of qi and blood loses, the invasion of wind-cold damp pathogen gas, add body constitution diminuendo after the prime of life, the ligament calcification, plump, between disk degeneration, bony spur forms, canalis spinalis narrows down, back pain, pressuring nerve, blood supply insufficiency, dizziness, headaches etc. are outbreak repeatedly, and wherein as often fatigue driving, the tired sitting of office, long-term sleeping posture is bad, pressuring nerve, passages through which vital energy circulates is not smooth, cause dizzy, symptoms such as pain are more obvious, collude the prominent joint fissure of displacement, increase also serious than other situation, and geneogenous bone is narrow, and is clinical comparatively rare, at present for the treatment of cervical spondylosis with traction, massage therapy, operation, diathermy, methods such as canalis sacralis injection are most, also have in the cooperation, the Western medicine therapeutic alliance, but all do not obtain ideal therapeutic effect, and treatment time is long, what have also may have side effects.And operative treatment risk height not only, and expense is big, can not receive ideal effect, easily recurrence, and do not see specific medicament on the market yet.
(3) summary of the invention
Purpose of the present invention just for the shortcoming that overcomes above-mentioned prior art with not enough, be the Chinese medicine of the treatment cervical spondylosis made according to a conventional method of raw material with Chinese medicine and provide a kind of, thereby can shorten the course of treatment that the reduction expense is effectively treated this kind disease.
The objective of the invention is to realize by following technical proposal: the Chinese medicine of treatment cervical spondylosis is characterized in that it is the capsule of being made according to a conventional method by the following weight proportion raw material:
Process or Myrrha (processed) 50-160 part, Pyritum (calcined) 25-80 part, system Massa Medicata Fermentata 30-95 part, Eupolyphaga Seu Steleophaga 15-50 part, Radix Notoginseng 10-40 part, Pheretima 75-240 part, give birth to Bombyx Batryticatus 50-160 part, Sanguis Draxonis 2-15 part, Margarita powder 1-5 part, Semen Strychni (processed) 180-600 part, process or Olibanum (processed) 50-150 part.
The Semen Strychni that Chinese medicine of the present invention is selected is a monarch drug, Myrrha, Olibanum, Pyritum, Sanguis Draxonis, Pheretima, Eupolyphaga Seu Steleophaga is a ministerial drug, Radix Notoginseng, Bombyx Batryticatus is an adjuvant drug, and Massa Medicata Fermentata is a messenger drug, wherein Semen Strychni has removing obstruction in the collateral to relieve pain, the effect of dispersing swelling and dissipating binds, Myrrha and Olibanum have promoting blood circulation and stopping pain, the effect of detumescence and promoting granulation, but Pyritum eliminating stasis to stop pain, synthetism is cured the wound, the Massa Medicata Fermentata stomach function regulating that can help digestion, but Eupolyphaga Seu Steleophaga removing blood stasis, reunion of fractured tendons and bones, but the Radix Notoginseng removing stasis to stop bleeding, the analgesic therapy of invigorating blood circulation, but Pheretima heat clearing away, endogenous wind stopping, current meridians, but Bombyx Batryticatus endogenous wind stopping relieving convulsion, wind-expelling pain-stopping, the effect of detoxifcation heat radiation, but Sanguis Draxonis promoting blood circulation to remove blood stasis pain relieving, Margarita powder has the relieving palpitation arresting convulsion, convergence granulation promoting, the Myrrha of processing and making, Olibanum and system Massa Medicata Fermentata can be brought into play the useful effect of medicine.
Entirely can blood circulation promoting and blood stasis dispelling, the gas of dredge the meridian passage, the wet exopathogen of removing cold and wind, simultaneously daily food and clothing is lived row, the life negative and positive, the elite of world nature and food is replenished necessary nutrition and element, and conditioning is local, the perforation human body is whole, reaches health QI-blood circulation balance again, reaches healthy.
Through clinical practice for many years, summed up three types of cervical spondylosis, be:
1, slight type: the state of an illness is shorter, has showed slight physiological curve and has changed the vertebral rim hypertrophy;
2, moderate type: performance shoulder arm pain, numbness, but the equal pain of pressures of swinging back, bow, cough with asthma, tinnitus otalgia, dizziness, grasp weakness, amyotrophy;
3, severe type: especially after the middle age, muscles and bones is slack, ligament is plump, nutrition operation profit and loss imbalance, and refuse or metabolite can not in time excrete, intercalated disc is further degenerated, and canalis spinalis is narrower, serious compressing spirit, serious blood supply insufficiency, life is inconvenience extremely.
4, atrophic: quadriplegia almost, clinical rare, few.
Chinese medicine of the present invention is to be taken at bed time every night to use once, and each 2-6g, does not aviod certain food for drawing with yellow wine, there is not any other taboo, during the night medication, because of human body fully loosens, muscle skeleton obtains necessary rest, spinal column is lowerd, no pressure, no external force is disturbed, and daytime, yang-energy was vigorous, evening, cloudy gas belonged to Liver and kidney, and medicine is effective function more.
Clinical observation:
Patient's 1370 examples, male 810 examples, women 560 examples, age 25-70 year, to add up by incidence type, treatment 1-2 course of treatment, be 40 days each course of treatment.Therapeutic outcome sees Table 1.
Table 1 therapeutic outcome statistics
The incidence type case load is cured the effectively invalid routine total effective rate of example of example
(man/woman) accounts for % and accounts for % and account for % and account for %
Intercalated disc dashes forward 500 (300/200) 405 81.00 85 17.00 10 2.00 98.00
Type
Hyperosteogeny type 350 (200/150) 297 84.86 47 13.40 6 1.71 98.29
Spinal canal stenosis type 240 (150/90) 204 85.00 33 13.70 3 1.25 98.75
Intercalated disc bulging type 100 (60/40) 84 84.00 15 15.00 1 1.00 99.00
Comprehensive morbidity type 180 (100/80) 146 81.10 30 16.70 4 2.22 97.78
Average 98.36
As can be seen from Table 1, Chinese medicine of the present invention is to the treatment of various types of cervical spondylosiss, and its effective percentage all can reach more than 98%.
Owing to take technique scheme, make the technology of the present invention have short treating period, instant effect, expense is low, has no side effect devoid of risk, no pain, cure rate height, advantage that does not recur and effect.
(4) specific embodiment
Embodiment 1
Make capsule according to a conventional method after getting Myrrha (processed) 105g, Pyritum (calcined) 50g, system Massa Medicata Fermentata 70g, Eupolyphaga Seu Steleophaga 30g, Radix Notoginseng 30g, Pheretima 170g, living Bombyx Batryticatus 100g, Sanguis Draxonis 8g, Margarita powder 1.5g, Semen Strychni (processed) 400g, Olibanum 110g mixing.
Embodiment 2
Make capsule according to a conventional method after getting Myrrha (processed) 130g, Pyritum (calcined) 60g, system Massa Medicata Fermentata 95g, Eupolyphaga Seu Steleophaga 35g, Radix Notoginseng 25g, Pheretima 200g, living Bombyx Batryticatus 150g, Sanguis Draxonis 10g, Margarita powder 3g, Semen Strychni (processed) 550g, Olibanum 150g mixing.
Embodiment 3
Make capsule according to a conventional method after getting Myrrha (processed) 65g, Pyritum (calcined) 25g, system Massa Medicata Fermentata 40g, Eupolyphaga Seu Steleophaga 20g, Radix Notoginseng 10g, Pheretima 80g, living Bombyx Batryticatus 70g, Sanguis Draxonis 5g, Margarita powder 1g, Semen Strychni (processed) 200g, Olibanum 50g mixing.
Embodiment 4
Make capsule according to a conventional method after getting Myrrha (processed) 160g, Pyritum (calcined) 80g, system Massa Medicata Fermentata 80g, Eupolyphaga Seu Steleophaga 15g, Radix Notoginseng 40g, Pheretima 75g, living Bombyx Batryticatus 160g, Sanguis Draxonis 2g, Margarita powder 5g, Semen Strychni (processed) 180g, Olibanum 130g mixing.
Embodiment 5
Make capsule according to a conventional method after getting Myrrha (processed) 50g, Pyritum (calcined) 40g, system Massa Medicata Fermentata 30g, Eupolyphaga Seu Steleophaga 50g, Radix Notoginseng 20g, Pheretima 240g, living Bombyx Batryticatus 50g, Sanguis Draxonis 15g, Margarita powder 2g, Semen Strychni (processed) 600g, Olibanum 70g mixing.
Claims (1)
1, the Chinese medicine of treatment cervical spondylosis is characterized in that it is the capsule of being made according to a conventional method by the following weight proportion raw material:
Process or Myrrha (processed) 50-160 part, Pyritum (calcined) 25-80 part, system Massa Medicata Fermentata 30-95 part, Eupolyphaga Seu Steleophaga 15-50 part, Radix Notoginseng 10-40 part, Pheretima 75-240 part, give birth to Bombyx Batryticatus 50-160 part, Sanguis Draxonis 2-15 part, Margarita powder 1-5 part, Semen Strychni (processed) 180-600 part, process or Olibanum (processed) 50-150 part.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021256470A CN1171617C (en) | 2002-04-10 | 2002-07-26 | Chinese medicine for treating cervical spondylosis |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02116833 CN1375328A (en) | 2002-04-10 | 2002-04-10 | Chinese medicine for treating cervical spondylopathy |
CN02116833.4 | 2002-04-10 | ||
CNB021256470A CN1171617C (en) | 2002-04-10 | 2002-07-26 | Chinese medicine for treating cervical spondylosis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1389256A CN1389256A (en) | 2003-01-08 |
CN1171617C true CN1171617C (en) | 2004-10-20 |
Family
ID=25741130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021256470A Expired - Fee Related CN1171617C (en) | 2002-04-10 | 2002-07-26 | Chinese medicine for treating cervical spondylosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1171617C (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101574501B (en) * | 2009-06-17 | 2011-08-17 | 于海燕 | Sanchi and combined spicebush root paste used for preventing and treating cervical spondylosis |
-
2002
- 2002-07-26 CN CNB021256470A patent/CN1171617C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1389256A (en) | 2003-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102670928B (en) | Plaster for treating cervical spondylosis and lumbar spondylosis | |
CN101361872A (en) | Traditional Chinese medicine for quickly treating bone fracture and postoperative nonunion and delayed healing | |
CN102908442A (en) | Composition for treating traumatic injuries and medicinal liquor thereof | |
CN1785343A (en) | Ready prepared Chinese medicine for treating epicophosis and sonitus | |
CN103800489B (en) | A kind of Chinese medicinal liquor for the treatment of cervical spondylosis and preparation method thereof | |
CN1171617C (en) | Chinese medicine for treating cervical spondylosis | |
CN1403141A (en) | Plaster for treating cervical spondylosis and lumbar vertebra disease | |
CN101543661A (en) | Low-frequency magnetic therapy apparatus and method for using same | |
CN1135909A (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
CN103463261B (en) | Traditional Chinese medicine preparation for treating lumbar intervertebral disc herniation | |
CN102526482A (en) | Traditional Chinese medicine preparation for treating lumbar disc herniation | |
CN1092982C (en) | Medicine for treating hyperosteogeny | |
CN1375328A (en) | Chinese medicine for treating cervical spondylopathy | |
CN1857636A (en) | Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny | |
CN103211978B (en) | Chinese medicine composition for treating kidney-yang deficiency type aplastic anemia | |
CN1284598C (en) | Medicine for treating epilepsia | |
CN103202641B (en) | A kind of cervical vertebrae correction therapeutic medicine-filled pillow | |
CN1723933A (en) | Traditional Chinese medicine capsule for treating application, and its prodn. method | |
CN1850238A (en) | Medicine composition for treating backbone and joint disease | |
CN1229118C (en) | Bone setting medicine | |
CN1850257A (en) | Bone-setting powder | |
CN1120014C (en) | Chinese patent medicine for treating hyperosteogeny | |
CN101229356B (en) | External wad for treating cervical spondylosis | |
CN1274346C (en) | Medication for treating prolapse of cervical intervertebral disc and prolapse of lumbar intervertebral disc | |
CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041020 Termination date: 20140726 |
|
EXPY | Termination of patent right or utility model |